The North Carolina company's recall covers 23 vials shipped nationwide. The FDA labeled it Class 2, meaning serious health effects are considered unlikely.
Recap by typeshit. Full story at Fox Business.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A $90 Brooklyn vial held a filler used in lip balm plus 13 bacteria colonies, University of Iowa testers said. Two online orders shipped with no consultation.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
Eight people sealed inside a glass dome ended up testing whether calorie restriction slows aging. Avi Roy looks back at what happened to them.
Unlike most weight loss treatments, CBL-514 is described as making fat cells die off rather than shrink. Early clinical results are reported as encouraging.
Loading…